Immunome Stock Forward View - Accumulation Distribution
| IMNM Stock | USD 25.07 0.32 1.29% |
Immunome Stock outlook is based on your current time horizon.
The value of RSI of Immunome's stock price is about 62. This usually indicates that the stock is rather overbought by investors as of now. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Immunome, making its price go up or down. Momentum 62
Buy Extended
Oversold | Overbought |
Using Immunome hype-based prediction, you can estimate the value of Immunome from the perspective of Immunome response to recently generated media hype and the effects of current headlines on its competitors.
Immunome after-hype prediction price | USD 25.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Immunome to cross-verify your projections. To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.Immunome Additional Predictive Modules
Most predictive techniques to examine Immunome price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immunome using various technical indicators. When you analyze Immunome charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 59635.57 | 48274.79 |
| Check Immunome Volatility | Backtest Immunome | Information Ratio |
Immunome Trading Date Momentum
| On January 29 2026 Immunome was traded for 25.07 at the closing time. The top price for the day was 25.61 and the lowest listed price was 24.28 . The trading volume for the day was 929.6 K. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.52% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Immunome to competition |
Other Forecasting Options for Immunome
For every potential investor in Immunome, whether a beginner or expert, Immunome's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immunome Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immunome. Basic forecasting techniques help filter out the noise by identifying Immunome's price trends.Immunome Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunome stock to make a market-neutral strategy. Peer analysis of Immunome could also be used in its relative valuation, which is a method of valuing Immunome by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Immunome Market Strength Events
Market strength indicators help investors to evaluate how Immunome stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunome shares will generate the highest return on investment. By undertsting and applying Immunome stock market strength indicators, traders can identify Immunome entry and exit signals to maximize returns.
Immunome Risk Indicators
The analysis of Immunome's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immunome's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immunome stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.59 | |||
| Semi Deviation | 3.97 | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.73 | |||
| Downside Variance | 19.65 | |||
| Semi Variance | 15.72 | |||
| Expected Short fall | (4.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Immunome
The number of cover stories for Immunome depends on current market conditions and Immunome's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immunome is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immunome's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Immunome Short Properties
Immunome's future price predictability will typically decrease when Immunome's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immunome often depends not only on the future outlook of the potential Immunome's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunome's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 58.6 M | |
| Cash And Short Term Investments | 217.3 M |
Check out Historical Fundamental Analysis of Immunome to cross-verify your projections. To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Will Stock sector continue expanding? Could Immunome diversify its offerings? Factors like these will boost the valuation of Immunome. Market participants price Immunome higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immunome data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Immunome requires distinguishing between market price and book value, where the latter reflects Immunome's accounting equity. The concept of intrinsic value—what Immunome's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immunome's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunome's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.